Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Hemosol to begin multinational phase III trials of Hemolink

March 15, 1999

FDA grants priority review status, sets date for advisory committee review of Actos

March 15, 1999

Long-term treatment with phen-fen associated with valvular abnormalities

March 15, 1999

FDA okays new indication and minimal liver function testing for Lescol

March 12, 1999

Health Canada approves Viagra

March 11, 1999

Greater reductions in LDL cholesterol lead to fewer cardiac events

March 11, 1999

FDA approves new therapy for type II diabetes

March 10, 1999

Series from Lilly especially useful for hypercholesterolemia in postmenopausal women

March 10, 1999

New patent strengthens Millennium's position on UCPH

March 9, 1999

Rhone-Poulenc Rorer claims series for diabetes and diabetic complications

March 9, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...